Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Kyblue1

(219 posts)
Thu Aug 4, 2022, 01:08 PM Aug 2022

Doesn't the rule prohibiting Soc Sec from negotiating for lower drug prices date back to GWB?

I haven’t heard any journalist mention the fact that it was during the administration of GWB that this rule was imposed. When AARP supported the rule I quit that organization.

3 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Doesn't the rule prohibiting Soc Sec from negotiating for lower drug prices date back to GWB? (Original Post) Kyblue1 Aug 2022 OP
It does. dflprincess Aug 2022 #1
Yes. It was baked into the Medicare Part D legislation... Wounded Bear Aug 2022 #2
It was worse than that genxlib Aug 2022 #3

Wounded Bear

(63,751 posts)
2. Yes. It was baked into the Medicare Part D legislation...
Thu Aug 4, 2022, 01:11 PM
Aug 2022

by repubs, of course. Everybody else negotiates, that law explicitly forbids Medicare from doing it.

genxlib

(6,077 posts)
3. It was worse than that
Thu Aug 4, 2022, 01:38 PM
Aug 2022

The Republican that was instrumental in putting the rule in went straight to work for the Pharma industry. It is one of the ugliest cases of payoff in recent history.

https://thehill.com/opinion/healthcare/374035-ex-congressman-still-costing-taxpayers-billions-in-prescription-fees/


Former Rep. Billy Tauzin (R,D-La.) and the Pharmaceutical Research and Manufacturers of America championed the “non-interference clause” being added to the Social Security law. According to 60 Minutes, Tauzin was responsible for successfully shepherding through Congress the bill limiting the government’s ability to bargain for better drug prices.

This was quite a “win” for the pharmaceutical industry and a loss for the American taxpayer. What happened to Tauzin? Surprise, surprise, he retired from Congress sometime after securing the favorable restriction and accepted a position as president of a trade association where he received $2 million a year.

Which trade association is paying him $2 million a year? I know you will find this shocking: the Pharmaceutical Research and Manufacturers of America.
Latest Discussions»General Discussion»Doesn't the rule prohibit...